Sulfinpyrazone after Myocardial Infarction

Anturane Reinfarction Trial Policy Committee

Research output: Contribution to journalLetterpeer-review

2 Scopus citations

Abstract

To the Editor: I should be obliged if the authors of the report on the Anturane Reinfarction Trial in the February 9 issue of the Journal could clarify one particular point — namely, the percentage of patients who continued smoking, on sulfinpyrazone, as compared to placebo. In the article, mention is only made for smoking before infarction, in which the two groups were comparable. Were any separate analyses done comparing groups of patients in the placebo and sulfinpyrazone groups, correcting for number of cigarettes smoked?.

Original languageEnglish (US)
Pages (from-to)1257-1259
Number of pages3
JournalNew England Journal of Medicine
Volume298
Issue number22
DOIs
StatePublished - Jun 1 1978

Fingerprint Dive into the research topics of 'Sulfinpyrazone after Myocardial Infarction'. Together they form a unique fingerprint.

Cite this